Kenneth Lock

Corporate Officer/Principal presso ACELYRIN, INC.

Patrimonio netto: 236 722 $ in data 30/06/2024

50 anni

Health Technology

Consumer Services

Posizioni attive di Kenneth Lock

Società	Posizione	Inizio	Fine
ACELYRIN, INC.	Corporate Officer/Principal	18/07/2023	-

Società	Posizione	Inizio	Fine
ARCUTIS BIOTHERAPEUTICS, INC.	Corporate Officer/Principal	01/01/2020	02/06/2023
GILEAD SCIENCES, INC.	Vendite & Marketing	01/12/2013	01/08/2019
AMGEN INC.	Corporate Officer/Principal	01/03/2007	01/11/2013
Wyeth Pharmaceuticals, Inc. Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford.	Corporate Officer/Principal	01/06/2003	01/02/2007
IDEC Pharmaceuticals Corp. IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA.	Corporate Officer/Principal	01/01/1996	-

Cornell University	Masters Business Admin
University of California San Diego	Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	5
Sales & Marketing	1
Masters Business Admin	1

Settori

Health Technology	7
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	4
ARCUTIS BIOTHERAPEUTICS, INC.	Health Technology
GILEAD SCIENCES, INC.	Health Technology
AMGEN INC.	Health Technology
ACELYRIN, INC.	Health Technology

Aziende private	2
Wyeth Pharmaceuticals, Inc. Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford.	Health Technology
IDEC Pharmaceuticals Corp. IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA.	Health Technology

Aziende private

Health Technology